GSK Investigational Site
Mysłowice 41-400
1 studies enrolling now · 7 studies all time
What they study most
Cholestasis, Chronic Hepatitis B, Hepatitis B, Hepatitis B, Chronic, Liver Diseases, Alcoholic
Studies at this site
- A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease — Recruiting now
- Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2) — Completed
- Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure) — Running, not enrolling
- Linerixibat Long-term Safety, and Tolerability Study — Running, not enrolling
- Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB) — Completed
- A Study of GSK3228836 in Participants With Chronic Hepatitis B (CHB) — Completed
- Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary Cholangitis — Completed